 Synthetic lethality with the topoisomerase inhibitor irinotecan appears to occur when given to cancer patients with deficient expression of the DNA repair gene "WRN".The analysis of 630 human primary tumors in 11 tissues shows that hypermethylation of the "WRN" CpG island promoter (with loss of expression of WRN protein) is a common event in tumorigenesis.